Ian Amanna
Associate Vice President for Research
Akorn
Romania
Biography
His publication on the duration of vaccine-induced immunity published in the New England Journal of Medicine (Amanna et al. NEJM 2007; 1903-15) was ranked by the Amedeo Medical Literature Service as one of the top 10 most influential papers published in 2007 (http://www.amedeoprize.com/). Dr. Amanna oversees the operations at NTI’s research and development laboratories, in addition to management of outside contract research activities in support of NTI’s vaccine.Dr. Amanna received his PhD from the Department of Biochemistry at the University of Wisconsin-Madison, followed by a post-doctoral fellowship at the OHSU Vaccine & Gene Therapy Institute (VGTI) in Beaverton, OR. Dr. Amanna was originally recruited to Najít Technologies as Director of Research in 2007, and in 2010 he was promoted to Associate Vice President for Research.
Research Interest
Immunology
